Connecticut 2022 Regular Session

Connecticut House Bill HB05044

Introduced
2/10/22  
Refer
2/10/22  
Report Pass
3/11/22  
Refer
3/21/22  
Refer
3/21/22  
Report Pass
3/28/22  
Refer
4/13/22  
Refer
4/13/22  
Report Pass
4/18/22  
Engrossed
4/26/22  
Engrossed
4/26/22  
Report Pass
4/27/22  
Passed
5/3/22  
Passed
5/3/22  
Chaptered
5/10/22  
Chaptered
5/10/22  
Enrolled
5/17/22  

Caption

An Act Implementing The Governor's Budget Recommendations Regarding The Use Of Opioid Litigation Proceeds.

Impact

The implication of HB 5044 on state laws is significant as it shifts how opioid litigation proceeds are managed and utilized. This legislation ensures that the funds are earmarked specifically for substance use disorder initiatives and mandates that these resources supplement rather than replace existing state and federal funds. By aligning funding with evidence-based strategies, the bill sets a framework for effectively combating the opioid crisis while promoting community health.

Summary

House Bill 5044, also known as the Opioid Settlement Fund Act, establishes a dedicated fund to manage proceeds received by the state from opioid litigation. The bill aims to allocate these funds to support programs and infrastructure that address substance use disorders, utilizing a structured approach to enhance prevention, treatment, recovery, and harm reduction services. It proposes the creation of an Opioid Settlement Advisory Committee to oversee fund distribution and to ensure transparency in the spending process.

Sentiment

The sentiment around HB 5044 generally reflects bipartisan support, recognizing the urgent need to address the opioid crisis. However, there are concerns regarding the operationalization of fund management and accountability. Stakeholders and community advocates are cautiously optimistic about the bill, hoping it will lead to meaningful progress in substance use treatment and harm reduction outcomes while ensuring that invested funds yield tangible benefits.

Contention

Notable points of contention include the potential for bureaucratic delays in fund distribution and the challenges of equitable access to services across different communities. Critics argue that while the bill establishes a framework for funding, the execution will be key to its success. Furthermore, discussions surrounding the adequacy of community involvement in decision-making processes suggest a need for ongoing dialogue to balance state-level authority with local needs.

Companion Bills

No companion bills found.

Similar Bills

CT HB06696

An Act Concerning The Opioid Settlement Fund And Personal Opioid Drug Deactivation And Disposal Products.

CT HB06914

An Act Concerning The Use Of Funds In The Opioid And Tobacco Settlement Funds And Funds Received By The State As Part Of Any Settlement Agreement With A Manufacturer Of Electronic Nicotine Delivery System And Vapor Products.

CT SB01163

An Act Authorizing The Use Of Opioid Settlement Funds To Provide Municipal Police Officers With Opioid Antagonists.

CT HB05249

An Act Concerning Personal Opioid Drug Deactivation And Disposal Systems And The Opioid Settlement Fund.

CT HB06698

An Act Concerning Drug Policy, Substance Abuse And Peer Support Services.

CT HB05511

An Act Concerning The Opioid Settlement Advisory Committee.

HI HB2806

Relating To Opioid Litigation Proceeds.

LA HB1045

Provides relative to funding for certain substance abuse services (OR INCREASE SD RV See Note)